Clinical Trials

223 enrolled 14 charts

Prostatic Neoplasms

NCT04435756 2026-03-12

A Study of miRNA 371 in Patients With Germ Cell Tumors

Active not recruiting

956 enrolled

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Seminoma

NCT02905318 2026-03-09

Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer

19 enrolled

Phase NA Active not recruiting

Prostatic Neoplasms

NCT04467021 2026-03-02

Cancer and Blood Pressure Management, CARISMA Study

61 enrolled

Carcinoma, Renal Cell, Cardiovascular Diseases, Carcinoma, Medullary, Renal Insufficiency, Chronic

NCT04484818 2026-03-02

Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study

27 enrolled

Prostatic Neoplasms

NCT04597359 2026-03-02

To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

360 enrolled

Prostatic Neoplasms

NCT05538663 2026-03-02

BRIDGE

870 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05863351 2026-03-02

Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study

472 enrolled

Carcinoma, Renal Cell

NCT03768570 2026-02-02

Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer

82 enrolled

Phase NA Active not recruiting

Urinary Bladder Neoplasms

NCT03784755 2025-11-20

PLATON

409 enrolled

Prostate Cancer Metastatic

NCT04663997 2025-11-06

177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer

200 enrolled

Prostatic Neoplasms

NCT01368588 2025-10-28

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

2,592 enrolled

Prostatic Neoplasms

NCT02194842 2025-09-19

PEACE III

446 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT02972060 2025-09-19

ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer

61 enrolled

Prostatic Neoplasms

NCT01230866 2025-09-04

Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer

150 enrolled

Prostatic Neoplasms

NCT03385655 2025-08-21

Prostate Cancer Biomarker Enrichment and Treatment Selection

200 enrolled

Prostatic Neoplasms

NCT00945009 2025-05-31

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

249 enrolled 14 charts

Beckwith-Wiedemann Syndrome, Wilms Tumor

NCT03757949 2025-05-15

Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery

203 enrolled 9 charts

Urinary Bladder Neoplasms

NCT00567580 2025-05-09

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

1,792 enrolled 27 charts

Phase NA Active not recruiting

Prostatic Neoplasms

NCT02960087 2025-04-15

Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

334 enrolled

Prostatic Neoplasms

NCT03091660 2025-04-02

S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer

1,000 enrolled

Stage 0 Bladder Urothelial Carcinoma

NCT00898365 2025-03-25

Study of Kidney Tumors in Younger Patients

Active not recruiting

8,000 enrolled

Oncocytoma, renal, Carcinoma, Renal Cell, Kidney Neoplasms, Wilms Tumor, Nephroma, Mesoblastic, Angiolipoma

NCT02799706 2024-11-05

PEGASUS

885 enrolled

Phase 1 Active not recruiting

Prostatic Neoplasms

NCT04134000 2024-05-21

BladderGATE

40 enrolled